Clinical trial explores new glioblastoma treatment regimen

May 22, 2017

On average, a patient with glioblastoma lives for only about a year after diagnosis. In a new clinical trial, CCR researchers will test whether a combination of a vaccine made from the patient’s tumor with another immunotherapy treatment can increase survival rates. Read more...

 

Clinical trial explores new glioblastoma treatment regimen
Kristy and her daugher Jane

A Conversation with Kristy and Jane

May 17, 2017

Jane has been coming to the NIH Clinical Center for treatment for neurofibromatosis type 1 (NF1) since she was three years old. She is currently enrolled in a trial that tests Selumetinib, a MEK inhibitor, and her tumor is now 30.7 percent smaller than when she first started this trial three years ago. Her diagnosis has changed the lives of her family but has also given them new passions and perseverance. Read more...

A Conversation with Kristy and Jane

Clinical trial studies new therapy in children and adults with neurofibromatosis-related GIST

May 15, 2017

A new clinical trial studies how treatment with a protein kinase inhibitor effects NF1-related GIST in children and young adults. Learn more...

Clinical trial studies new therapy in children and adults with neurofibromatosis-related GIST

Clinical trial shows safety and effectiveness of new combination immunotherapy for advanced liver cancer

May 8, 2017

A recently completed phase I clinical trial at the NIH Clinical Center in Bethesda, Maryland, demonstrates that a combination of two immunotherapy drugs to target hepatocellular carcinoma (HCC) was well-tolerated and shrunk tumors in a larger percentage of patients than the standard monotherapy.  Read more...

Clinical trial shows safety and effectiveness of new combination immunotherapy for advanced liver cancer

New clinical trial studies two-part treatment for patients with gastric cancer

May 1, 2017

A new clinical trial is open to test a two-part treatment for stomach cancer that has spread to the peritoneum.
Learn more...

New clinical trial studies two-part treatment for patients with gastric cancer

New clinical trial opens to determine safety and efficacy of PROSTVAC, nivolumab and ipilimumab in men with localized prostate cancer

Apr 24, 2017

A new study is now open to evaluate the safety and effectiveness of a treatment regimen that combines PROSTVAC with ipilimumab and/or nivolumab in men with localized prostate cancer who have elected to undergo surgical resection (prostatectomy).  Learn more...

New clinical trial opens to determine safety and efficacy of PROSTVAC, nivolumab and ipilimumab in men with localized prostate cancer

Clinical trial studies a new form of vincristine in standard combination chemotherapy for children with relapsed ALL

Apr 20, 2017

A combination of chemotherapy drugs known by the regimen UK ALL R3 is one of the most successful treatments for patients with relapsed acute lymphoblastic leukemia (ALL). In this study, investigators hope to improve outcomes by combining the treatment with Marqibo, a new formulation of the drug vincristine. Learn more...

Clinical trial studies a new form of vincristine in standard combination chemotherapy for children with relapsed ALL

Pages